Related Experiment Video
Updated: Dec 31, 2025

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
[Small fibre neuropathy: A review].
C Contijoch Roqueta1, M F Izquierdo1, L Arrabal Solano1
1Medicina Familiar y Comunitaria, Area Básica de Salud Poblenou, Institut Català de la Salut, Barcelona, España.
Small fibre neuropathy causes chronic neuropathic pain and autonomic dysfunction by affecting small nerve fibres. Diagnosis requires specialized tests beyond routine neurophysiology, emphasizing early awareness for effective treatment.
Area of Science:
- Neurology
- Peripheral Nervous System Disorders
Background:
- Small fibre neuropathy (SFN) is a peripheral nervous system disorder.
- It primarily impacts small myelinated (Aδ) and non-myelinated (C) nerve fibres.
- Clinical manifestations include chronic neuropathic pain and autonomic nervous system alterations.
Purpose of the Study:
- To highlight the diagnostic challenges of small fibre neuropathy.
- To emphasize the importance of recognizing SFN for timely diagnosis and treatment.
- To discuss the primary and secondary causes of SFN.
Main Methods:
- Routine neurophysiological tests are often negative in SFN.
- Diagnostic confirmation relies on specialized tests like microneurography and sensory stimulation tests.
- Skin biopsy is a commonly utilized diagnostic technique.
Main Results:
- SFN presents with diverse symptoms, complicating diagnosis.
- Standard neurophysiological assessments lack sensitivity for SFN.
- Advanced diagnostic methods are crucial for identifying the condition.
Conclusions:
- Early clinical suspicion and awareness of SFN are vital.
- Access to specialized diagnostic tools is essential, especially from Primary Health Care.
- Treatment targets both the underlying causes and neurological symptoms of SFN.
More Related Videos
Related Concept Videos
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

